These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 8020077

  • 1. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A, Erasmus RT, Anjorin SA.
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [Abstract] [Full Text] [Related]

  • 2. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO, Agbedana EO, Kadiri S, Taylor GO.
    Afr J Med Med Sci; 1999 Oct; 28(1-2):97-100. PubMed ID: 12953996
    [Abstract] [Full Text] [Related]

  • 3. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
    Prata MM, Nogueira AC, Pinto JR, Correia AM, Vicente O, Rodrigues MC, Miguel MJ.
    Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207
    [Abstract] [Full Text] [Related]

  • 4. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
    Antikainen M, Holmberg C, Taskinen MR.
    Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
    [Abstract] [Full Text] [Related]

  • 5. The effects of coffee consumption on serum lipids and lipoprotein in healthy individuals.
    Onuegbu AJ, Agbedana EO.
    Afr J Med Med Sci; 2001 May; 30(1-2):43-5. PubMed ID: 14510149
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein A and high density lipoprotein cholesterol in childhood nephrotic syndrome.
    Agbedana EO, Taylor GO, Folami AO.
    East Afr Med J; 1990 Apr; 67(4):279-85. PubMed ID: 2364904
    [Abstract] [Full Text] [Related]

  • 7. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity.
    Appel GB, Blum CB, Chien S, Kunis CL, Appel AS.
    N Engl J Med; 1985 Jun 13; 312(24):1544-8. PubMed ID: 3858668
    [Abstract] [Full Text] [Related]

  • 8. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 13; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 9. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK, Arora RC, Agarwal N, Garg RK, Arora S, Gurbaxani RK, Sharma D.
    J Assoc Physicians India; 1991 Oct 13; 39(10):751-3. PubMed ID: 1816199
    [Abstract] [Full Text] [Related]

  • 10. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M, Salamatullah Q, Ferdous Z, Hussain MA.
    Bangladesh Med Res Counc Bull; 1976 Jun 13; 2(1):64-70. PubMed ID: 190998
    [Abstract] [Full Text] [Related]

  • 11. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R.
    Contraception; 2004 Apr 13; 69(4):271-8. PubMed ID: 15033400
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M, Taş S, Sarandöl E, Tokullugil HA.
    Kobe J Med Sci; 1998 Dec 13; 44(5-6):235-45. PubMed ID: 10401226
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet.
    Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, Green PH.
    Am J Med; 2006 Sep 13; 119(9):786-90. PubMed ID: 16945614
    [Abstract] [Full Text] [Related]

  • 15. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR, Engstrand S, Berglin E, Johnson O.
    Scand J Rheumatol; 2006 Sep 13; 35(2):107-11. PubMed ID: 16641043
    [Abstract] [Full Text] [Related]

  • 16. [Effects of high-carbohydrate/low-fat diet on serum lipid ratios in healthy young subjects].
    Gan CF, Gong RR, Lin J, Li ZK, Tang H, Huang X, Li RH, Fang DZ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar 13; 39(2):267-71, 275. PubMed ID: 18630700
    [Abstract] [Full Text] [Related]

  • 17. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Mar 13; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 18. Lipid profile of term infants on exclusive breastfeeding and mixed feeding: a comparative study.
    Harit D, Faridi MM, Aggarwal A, Sharma SB.
    Eur J Clin Nutr; 2008 Feb 13; 62(2):203-9. PubMed ID: 17327867
    [Abstract] [Full Text] [Related]

  • 19. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
    Wanner C, Krämer-Guth A, Nauck M, Quaschning T, Pavenstädt H, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Feb 13; 22(1-3):39-46. PubMed ID: 8676822
    [Abstract] [Full Text] [Related]

  • 20. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 13; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.